Merck Serono and Mersana Collaborate on Antibody Drug Conjugates

25.06.2014 - Merck Serono, the biopharmaceutical division of Germany's Merck KGaA, and US company Mersana Therapeutics, based in Cambridge, Massachusetts, have agreed to collaborate on...